Literature DB >> 28065934

Brain cannabinoid receptor 2: expression, function and modulation.

De-Jie Chen1,2, Ming Gao2, Fen-Fei Gao2,3, Quan-Xi Su1, Jie Wu1,2,3.   

Abstract

Cannabis sativa (marijuana) is a fibrous flowering plant that produces an abundant variety of molecules, some with psychoactive effects. At least 4% of the world's adult population uses cannabis annually, making it one of the most frequently used illicit drugs in the world. The psychoactive effects of cannabis are mediated primarily through cannabinoid receptor (CBR) subtypes. The prevailing view is that CB1Rs are mainly expressed in the central neurons, whereas CB2Rs are predominantly expressed in peripheral immune cells. However, this traditional view has been challenged by emerging strong evidence that shows CB2Rs are moderately expressed and function in specific brain areas. New evidence has demonstrated that brain CB2Rs modulate animal drug-seeking behaviors, suggesting that these receptors may exist in brain regions that regulate drug addiction. Recently, we further confirmed that functional CB2Rs are expressed in mouse ventral tegmental area (VTA) dopamine (DA) neurons and that the activation of VTA CB2Rs reduces neuronal excitability and cocaine-seeking behavior. In addition, CB2R-mediated modulation of hippocampal CA3 neuronal excitability and network synchronization has been reported. Here, we briefly summarize recent lines of evidence showing how CB2Rs modulate function and pathophysiology in the CNS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28065934      PMCID: PMC5342669          DOI: 10.1038/aps.2016.149

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  76 in total

Review 1.  The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies.

Authors:  Jack Rocky-Jay Rivers; John Clive Ashton
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2010-03

2.  Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.

Authors:  Q-R Liu; C-H Pan; A Hishimoto; C-Y Li; Z-X Xi; A Llorente-Berzal; M-P Viveros; H Ishiguro; T Arinami; E S Onaivi; G R Uhl
Journal:  Genes Brain Behav       Date:  2009-06-03       Impact factor: 3.449

3.  Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

Authors:  J Agudo; M Martin; C Roca; M Molas; A S Bura; A Zimmer; F Bosch; R Maldonado
Journal:  Diabetologia       Date:  2010-09-11       Impact factor: 10.122

Review 4.  Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Authors:  Nephi Stella
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

5.  Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.

Authors:  John C Ashton; Deborah Friberg; Cynthia L Darlington; Paul F Smith
Journal:  Neurosci Lett       Date:  2005-12-13       Impact factor: 3.046

Review 6.  Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.

Authors:  J P Little; E B Villanueva; A Klegeris
Journal:  Mini Rev Med Chem       Date:  2011-06       Impact factor: 3.862

7.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Authors:  A R Schatz; M Lee; R B Condie; J T Pulaski; N E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  1997-02       Impact factor: 4.219

Review 8.  Cannabinoid type 2 receptor as a target for chronic - pain.

Authors:  Massimiliano Beltramo
Journal:  Mini Rev Med Chem       Date:  2009-01       Impact factor: 3.862

9.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

Review 10.  The peripheral cannabinoid receptor knockout mice: an update.

Authors:  N E Buckley
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more
  40 in total

1.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

2.  Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex.

Authors:  Changrui Xing; Youwen Zhuang; Ting-Hai Xu; Zhiwei Feng; X Edward Zhou; Maozi Chen; Lei Wang; Xing Meng; Ying Xue; Junmei Wang; Heng Liu; Terence Francis McGuire; Gongpu Zhao; Karsten Melcher; Cheng Zhang; H Eric Xu; Xiang-Qun Xie
Journal:  Cell       Date:  2020-01-30       Impact factor: 41.582

Review 3.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 4.  Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.

Authors:  J M Wenzel; J F Cheer
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

5.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

6.  Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.

Authors:  Lindsey Shapiro; Jennifer C Wong; Andrew Escayg
Journal:  Epilepsia       Date:  2019-11-22       Impact factor: 5.864

Review 7.  Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.

Authors:  Ruiqing Ni; Linjing Mu; Simon Ametamey
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

8.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies.

Authors:  Hai-Ying Zhang; Hui Shen; Chloe J Jordan; Qing-Rong Liu; Eliot L Gardner; Antonello Bonci; Zheng-Xiong Xi
Journal:  Acta Pharmacol Sin       Date:  2018-07-02       Impact factor: 6.150

Review 10.  Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression.

Authors:  Ferenc Zádor; Sâmia Joca; Gábor Nagy-Grócz; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Sándor Benyhe; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.